Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis

Toxicology

Volumn 303, Issue , 2013, Pages 139-146

  Wang, Heyong ^a   Zhang, Huijun ^a   Tang, Liang ^a   Chen, Haixia ^a   Wu, Chunlian ^a,b   Zhao, Mingchuan ^a   Yang, Yaoqin ^a   Chen, Xiaofeng ^a   Liu, Gentao ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINA WEST NORMAL UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition (EMT); Invasion and metastasis; Lung cancer; Resveratrol; TGF 1

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; RESVERATROL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAI1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; EPITHELIAL MESENCHYMAL TRANSITION; IN VITRO STUDY; LUNG CANCER; LUNG METASTASIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; STILBENES; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

VITACEAE;

EID: 84870899757     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.09.017     Document Type: Article

References (52)

1. Ackland M.L., Newgreen D.F., Fridman M., Waltham M.C., Arvanitis A., Minichiello J., Price J.T., Thompson E.W. Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab. Invest. 2003, 83:435-448.
2. Asiedu M.K., Ingle J.N., Behrens M.D., Radisky D.C., Knutson K.L. TGFβ/TNFα-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011, 71:4707-4719.
3. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
4. Bisht K., Wagner K.H., Bulmer A.C. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 2010, 278:88-100.
5. Busquets S., Ametller E., Fuster G., Olivan M., Raab V., Argilés J.M., López-Soriano F.J. Resveratrol a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett. 2007, 245:144-148.
6. Cai Z., Wang Q., Zhou Y., Zheng L., Chiu J.F., He Q.Y. Epidermal growth factor-induced epithelial-mesenchymal transition in human esophageal carcinoma cells-a model for the study of metastasis. Cancer Lett. 2010, 296:88-95.
7. Chang C.J., Chao C.H., Xia W., Yang J.Y., Xiong Y., Li C.W., Yu W.H., Rehman S.K., Hsu J.L., Lee H.H., Liu M., Chen C.T., Yu D., Hung M.C. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 2011, 13:317-323.
8. Chen X.F., Zhang H.J., Wang H.B., Zhu J., Zhou W.Y., Zhang H., Zhao M.C., Su J.M., Gao W., Zhang L., Fei K., Zhang H.T., Wang H.Y. Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Mol. Biol. Rep. 2012, 39:3549-3556.
9. Cheng Z.X., Sun B., Wang S.J., Gao Y., Zhang Y.M., Zhou H.X., Jia G., Wang Y.W., Kong R., Pan S.H., Xue D.B., Jiang H.C., Bai X.W. Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions. PLoS ONE 2011, 6:e23752.
10. Copple B.L. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010, 30:669-682.
11. Cullen J.P., Morrow D., Jin Y., von Offenberg Sweeney N., Sitzmann J.V., Cahill P.A., Redmond E.M. Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. Atherosclerosis 2007, 195:e125-e133.
12. Danz E.D., Skramsted J., Henry N., Bennett J.A., Keller R.S. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic. Biol. Med. 2009, 46:1589-1597.
13. Du R., Sun W., Xia L., Zhao A., Yu Y., Zhao L., Wang H., Huang C., Sun S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE 2012, 7:e30771.
14. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011, 71:5296-5306.
15. Floyd Z.E., Wang Z.Q., Kilroy G., Cefalu W.T. Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism 2008, 57:S32-S38.
16. Gjerdrum C., Tiron C., Høiby T., Stefansson I., Haugen H., Sandal T., Collett K., Li S., McCormack E., Gjertsen B.T., Micklem D.R., Akslen L.A., Glackin C., Lorens J.B. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1124-1129.
17. Gonzalez-Moreno O., Lecanda J., Green J.E., Segura V., Catena R., Serrano D., Calvo A. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Exp. Cell Res. 2010, 316:554-567.
18. Ikushima H., Miyazono K. TGFβ signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
19. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
20. Knobloch J., Hag H., Jungck D., Urban K., Koch A. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease. Basic Clin. Pharmacol. Toxicol. 2011, 109:138-143.
21. Kong D., Wang Z., Sarkar S.H., Li Y., Banerjee S., Saliganan A., Kim H.R., Cher M.L., Sarkar F.H. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 2008, 26:1425-1435.
22. Kundu J.K., Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269:243-261.
23. Lee S.Y., Lee H.J., Sikder M.A., Shin H.D., Kim J.H., Chang G.T., Seok J.H., Lee C.J. Resveratrol inhibits mucin gene expression production and secretion from airway epithelial cells. Phytother. Res. 2012, 26:1082-1087.
24. Li J., Qu X., Ricardo S.D., Bertram J.F., Nikolic-Paterson D.J. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am. J. Pathol. 2010, 177:1065-1071.
25. Li T., Fan G.X., Wang W., Li T., Yuan Y.K. Resveratrol induces apoptosis influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo. Int. Immunopharmacol. 2007, 7:1221-1231.
26. Liu P.L., Tsai J.R., Charles A.L., Hwang J.J., Chou S.H., Ping Y.H., Lin F.Y., Chen Y.L., Hung C.Y., Chen W.C., Chen Y.H., Chong I.W. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol. Nutr. Food Res. 2010, 54(Suppl. 2):S196-S204.
27. Lu Z.J., Ren Y.Q., Wang G.P., Song Q., Li M., Jiang S.S., Ning T., Guan Y.S., Yang J.L., Luo F. Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549. J. Exp. Clin. Cancer Res. 2009, 28:16.
28. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
29. Michels G., Wätjen W., Weber N., Niering P., Chovolou Y., Kampkötter A., Proksch P., Kahl R. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology 2006, 225:173-182.
30. Moon S.O., Kim W., Sung M.J., Lee S., Kang K.P., Kim D.H., Lee S.Y., So J.N., Park S.K. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells. Mol. Pharmacol. 2006, 70:112-119.
31. Moreno-Bueno G., Peinado H., Molina P., Olmeda D., Cubillo E., Santos V., Palacios J., Portillo F., Cano A. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat. Protoc. 2009, 4:1591-1613.
32. Olas B., Wachowicz B., Tomczak A., Erler J., Stochmal A., Oleszek W. Comparative anti-platelet and antioxidant properties of polyphenol-rich extracts from: berries of Aronia melanocarpa, seeds of grape and bark of Yucca schidigera in vitro. Platelets 2008, 19:70-77.
33. Onoue T., Uchida D., Begum N.M., Tomizuka Y., Yoshida H., Sato M. Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int. J. Oncol. 2006, 29:1133-1138.
34. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., Ke H., Rehmann H., Taussig R., Brown A.L., Kim M.K., Beaven M.A., Burgin A.B., Manganiello V., Chung J.H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
35. Qadri S.M., Föller M., Lang F. Inhibition of suicidal erythrocyte death by resveratrol. Life Sci. 2009, 85:33-38.
36. Shakibaei M., Harikumar K.B., Aggarwal B.B. Resveratrol addiction: to die or not to die. Mol. Nutr. Food Res. 2009, 53:115-128.
37. G12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS ONE 2011, 6:e16530.
38. Sun C., Hu Y., Liu X., Wu T., Wang Y., He W., Wei W. Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle and induction of apoptosis. Cancer Genet. Cytogenet. 2006, 165:9-19.
39. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
40. Tseng S.H., Lin S.M., Chen J.C., Su Y.H., Huang H.Y., Chen C.K. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer Res. 2004, 10:2190-2202.
41. Vergara D., Simeone P., Toraldo D., Del Boccio P., Vergaro V., Leporatti S., Pieragostino D., Tinelli A., De Domenico S., Alberti S., Urbani A., Salzet M., Santino A., Maffia M. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol. Biosyst. 2012, 8:1078-1087.
42. Vergara D., Valente C.M., Tinelli A., Siciliano C., Lorusso V., Acierno R., Giovinazzo G., Santino A., Storelli C., Maffia M. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett. 2011, 310:1-8.
43. Voulgari A., Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms markers and strategies to overcome drug resistance in the clinic. Biochim. Biophys. Acta 2009, 1796:75-90.
44. Xie D., Gore C., Liu J., Pong R.C., Mason R., Hao G., Long M., Kabbani W., Yu L., Zhang H., Chen H., Sun X., Boothman D.A., Min W., Hsieh J.T. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2485-2490.
45. Yadav A., Kumar B., Datta J., Teknos T.N., Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol. Cancer Res. 2011, 9:1658-1667.
46. Yang Y.T., Weng C.J., Ho C.T., Yen G.C. Resveratrol analog-3,5,4'-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol. Nutr. Food Res. 2009, 53:407-416.
47. 2 increases?. J. Cardiometab. Syndr. 2008, 3:30-34.
48. Zhang H., Liu H., Borok Z., Davies K.J., Ursini F., Forman H.J. Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation. Free Radic. Biol. Med. 2012, 52:1437-1442.
49. Zhang H.J., Wang H.Y., Zhang H.T., Su J.M., Zhu J., Wang H.B., Zhou W.Y., Zhang H., Zhao M.C., Zhang L., Chen X.F. Transforming growth factor-β1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition. Mol. Cell. Biochem. 2011, 355:309-314.
50. Zhang Q., Tang X., Lu Q.Y., Zhang Z.F., Brown J., Le A.D. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 2005, 4:1465-1474.
51. Zhong L.M., Zong Y., Sun L., Guo J.Z., Zhang W., He Y., Song R., Wang W.M., Xiao C.J., Lu D. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS ONE 2012, 7:e32195.
52. Zlotnik A., Burkhardt A.M., Homey B. Homeostatic chemokine receptors and organ-specific metastasis. Nat. Rev. Immunol. 2011, 11:597-606.